MHRA (UK)
OTHER
Field Safety Notices: 27 to 31 January 2025
Published: 10/16/2026Detected: 10/16/2026
Summary preview
Publication listing MHRA Field Safety Notices issued between 27 and 31 January 2025. Companies should review the included safety communications to identify any applicable products, distributor actions, labeling updates…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountsafety
quality
labeling
clinical
manufacturing
#MHRA
#Field Safety Notice
#FSN
#post-market surveillance
#safety communication
Official Source Document Source Verified
Access the original document directly from MHRA.
More from MHRA (UK)
- Nova Biomedical StatStrip ketone test strips: risk of disruption to blood ketone testing due to quality-control failures and supply interruption DSI/2026/01310/16/2026
- Continuous renal replacement therapy (CRRT): Consider delayed administration of concurrent echinocandins, such as caspofungin, to reduce the risk of adsorption onto new polyacrylonitrile (PAN)-based filter membranes DSI/2026/01410/13/2026
- Class 2 Medicines Recall: Norgine Pharmaceuticals Limited, Pedmarqsi 80 mg/mL solution for infusion, EL(26)A/4210/12/2026
- Field Safety Notices for October 202610/9/2026
- Field Safety Notices: 8 -12 June 202610/9/2026